Hu Y, Huang Y, Xie X, Li L, Zhang Y, Zhang X
Cancer Cell Int. 2023; 23(1):205.
PMID: 37716993
PMC: 10505330.
DOI: 10.1186/s12935-023-03053-y.
Jin M, Yu Q, Liu Y, Xu W, Fu X, Ji B
J Clin Transl Hepatol. 2021; 9(2):149-159.
PMID: 34007796
PMC: 8111114.
DOI: 10.14218/JCTH.2020.00125.
Zhang R, Chen Y, Zhou G, Sun B, Li Y, Chen Z
Evid Based Complement Alternat Med. 2021; 2020:8859558.
PMID: 33424998
PMC: 7781689.
DOI: 10.1155/2020/8859558.
Sojoodi M, Wei L, Erstad D, Yamada S, Fujii T, Hirschfield H
Cancer Prev Res (Phila). 2020; 13(6):497-508.
PMID: 32253266
PMC: 8340141.
DOI: 10.1158/1940-6207.CAPR-19-0383.
Li H, Wang X, Tang J, Zhao H, Duan M
Oncol Lett. 2019; 18(6):6214-6220.
PMID: 31788097
PMC: 6865704.
DOI: 10.3892/ol.2019.10974.
Altered epidermal fatty acid-binding protein expression in hepatocellular carcinoma predicts unfavorable outcomes.
Lu J, Cai S, Pan Y, Yun J
Cancer Manag Res. 2018; 10:6275-6284.
PMID: 30538573
PMC: 6260128.
DOI: 10.2147/CMAR.S181555.
Retinoblastoma Binding Protein 5 Correlates with the Progression in Hepatocellular Carcinoma.
Zhou H, Bao J, Zhu X, Dai G, Jiang X, Jiao X
Biomed Res Int. 2018; 2018:1073432.
PMID: 30533424
PMC: 6247687.
DOI: 10.1155/2018/1073432.
: a novel regulator in human cancer proliferation and metastasis.
Xue J, Huang C, Wang W, Li H, Sun M, Xie M
Onco Targets Ther. 2018; 11:4387-4393.
PMID: 30100744
PMC: 6067783.
DOI: 10.2147/OTT.S166961.
Investigating Effect of Rapamycin and Metformin on Angiogenesis in Hepatocellular Carcinoma Cell Line.
Rastegar M, Marjani H, Yazdani Y, Shahbazi M, Golalipour M, Farazmandfar T
Adv Pharm Bull. 2018; 8(1):63-68.
PMID: 29670840
PMC: 5899784.
DOI: 10.15171/apb.2018.008.
Downstaging for hepatocellular cancer: harm or benefit?.
Bryce K, Tsochatzis E
Transl Gastroenterol Hepatol. 2018; 2:106.
PMID: 29354763
PMC: 5763034.
DOI: 10.21037/tgh.2017.11.18.
Decreased expression of long non-coding RNA LOC728290 in human hepatocellular carcinoma.
Zhang S, Li Y, Zhao N, Lai C, Cheng S, Yan J
Oncol Lett. 2017; 14(4):4551-4556.
PMID: 29085452
PMC: 5649533.
DOI: 10.3892/ol.2017.6776.
TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma.
Dong Q, Fu L, Zhao Y, Xie C, Li Q, Wang E
Oncotarget. 2017; 8(9):15689-15703.
PMID: 28152516
PMC: 5362516.
DOI: 10.18632/oncotarget.14938.
Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis.
Xiao Q, Fu B, Chen P, Liu Z, Wang W, Ye Q
Medicine (Baltimore). 2016; 95(50):e5609.
PMID: 27977601
PMC: 5268047.
DOI: 10.1097/MD.0000000000005609.
Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis.
Kim H, Shen Q, Nam S
J Korean Med Sci. 2015; 30(10):1375-80.
PMID: 26425032
PMC: 4575924.
DOI: 10.3346/jkms.2015.30.10.1375.
Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
Zhang S, Shi W, Chen Y, Xu Z, Zhu J, Zhang T
Mol Cell Biochem. 2015; 410(1-2):1-9.
PMID: 26260052
DOI: 10.1007/s11010-015-2533-9.
Body Mass Index and Waistline are Predictors of Survival for Hepatocellular Carcinoma After Hepatectomy.
Liu X, Xu J
Med Sci Monit. 2015; 21:2203-9.
PMID: 26223028
PMC: 4523070.
DOI: 10.12659/MSM.894202.
MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.
Yang X, Ye J, Yan H, Tang Z, Shen J, Zhang J
Tumour Biol. 2015; 37(1):201-9.
PMID: 26188902
DOI: 10.1007/s13277-015-3687-5.
Upregulated expression of polycomb protein Ring1 contributes to poor prognosis and accelerated proliferation in human hepatocellular carcinoma.
Xiong Y, Hu B, Wei L, Jiang D, Zhu M
Tumour Biol. 2015; 36(12):9579-88.
PMID: 26141041
DOI: 10.1007/s13277-015-3721-7.
Suppression of the nuclear transporter-KPNβ1 expression inhibits tumor proliferation in hepatocellular carcinoma.
Yang L, Hu B, Zhang Y, Qiang S, Cai J, Huang W
Med Oncol. 2015; 32(4):128.
PMID: 25794490
DOI: 10.1007/s12032-015-0559-1.
ART and science in using transarterial chemoembolization for retreating patients with hepatocellular carcinoma.
Fatourou E, Tsochatzis E
Hepatobiliary Surg Nutr. 2015; 3(6):415-8.
PMID: 25568865
PMC: 4273114.
DOI: 10.3978/j.issn.2304-3881.2014.07.01.
